Suppr超能文献

评估美国癌症患者的医疗和公共援助支出及就业情况。

Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses.

机构信息

Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.

GRAIL, LLC, Menlo Park, California.

出版信息

JAMA Netw Open. 2023 May 1;6(5):e2315823. doi: 10.1001/jamanetworkopen.2023.15823.

Abstract

IMPORTANCE

Prior research suggests significant social value associated with increased longevity due to preventing and treating cancer. Other social costs associated with cancer, such as unemployment, public medical spending, and public assistance, may also be sizable.

OBJECTIVE

To examine whether a cancer history is associated with receipt of disability insurance, income, employment, and medical spending.

DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the Medical Expenditure Panel Study (MEPS) (2010-2016) for a nationally representative sample of US adults aged 50 to 79 years. Data were analyzed from December 2021 to March 2023.

EXPOSURE

Cancer history.

MAIN OUTCOMES AND MEASURES

The main outcomes were employment, public assistance receipt, disability, and medical expenditures. Variables for race, ethnicity, and age were used as controls. A series of multivariate regression models were used to assess the immediate and 2-year association of a cancer history with disability, income, employment, and medical spending.

RESULTS

Of 39 439 unique MEPS respondents included in the study, 52% were female, and the mean (SD) age was 61.44 (8.32) years; 12% of respondents had a history of cancer. Individuals with a cancer history who were aged 50 to 64 years were 9.80 (95% CI, 7.35-12.25) percentage points more likely to have a work-limiting disability and were 9.08 (95% CI, 6.22-11.94) percentage points less likely to be employed compared with individuals in the same age group without a history of cancer. Nationally, cancer accounted for 505 768 fewer employed individuals in the population aged 50 to 64 years. A cancer history was also associated with an increase of $2722 (95% CI, $2131-$3313) in medical spending, $6460 (95% CI, $5254-$7667) in public medical spending, and $515 (95% CI, $337-$692) in other public assistance spending.

CONCLUSIONS AND RELEVANCE

In this cross-sectional study, a history of cancer was associated with increased likelihood of disability, higher medical spending, and decreased likelihood of employment. These findings suggest there may be gains beyond increased longevity if cancer can be detected and treated earlier.

摘要

重要性

先前的研究表明,由于预防和治疗癌症,与延长寿命相关的社会效益巨大。与癌症相关的其他社会成本,如失业、公共医疗支出和公共援助,也可能相当可观。

目的

研究癌症病史是否与获得残疾保险、收入、就业和医疗支出有关。

设计、地点和参与者:这项横断面研究使用了来自医疗支出面板研究(MEPS)(2010-2016 年)的数据,该研究针对的是年龄在 50 至 79 岁的美国成年人的全国代表性样本。数据于 2023 年 3 月进行了分析。

暴露

癌症病史。

主要结果和措施

主要结果是就业、公共援助领取、残疾和医疗支出。种族、族裔和年龄变量被用作对照。使用一系列多变量回归模型来评估癌症病史与残疾、收入、就业和医疗支出的即时和 2 年关联。

结果

在纳入研究的 39439 名独特的 MEPS 受访者中,52%为女性,平均(SD)年龄为 61.44(8.32)岁;12%的受访者有癌症病史。50 至 64 岁的癌症病史患者工作受限残疾的可能性高 9.80(95%CI,7.35-12.25)个百分点,与同年龄段无癌症病史的患者相比,就业的可能性低 9.08(95%CI,6.22-11.94)个百分点。在全国范围内,癌症导致 50 至 64 岁人群中减少了 505768 名就业人员。癌症病史还与医疗支出增加 2722 美元(95%CI,2131 美元至 3313 美元)、公共医疗支出增加 6460 美元(95%CI,5254 美元至 7667 美元)和其他公共援助支出增加 515 美元(95%CI,337 美元至 692 美元)有关。

结论和相关性

在这项横断面研究中,癌症病史与残疾可能性增加、医疗支出增加以及就业可能性降低有关。这些发现表明,如果癌症能够更早地被发现和治疗,除了延长寿命之外,可能还会有更多的收益。

相似文献

1
Assessment of Medical and Public Assistance Expenditures and Employment Among US Adults With Cancer Diagnoses.
JAMA Netw Open. 2023 May 1;6(5):e2315823. doi: 10.1001/jamanetworkopen.2023.15823.
2
State Public Assistance Spending and Survival Among Adults With Cancer.
JAMA Netw Open. 2023 Sep 5;6(9):e2332353. doi: 10.1001/jamanetworkopen.2023.32353.
3
Trends in the Concentration and Distribution of Health Care Expenditures in the US, 2001-2018.
JAMA Netw Open. 2021 Sep 1;4(9):e2125179. doi: 10.1001/jamanetworkopen.2021.25179.
5
Supplemental Nutrition Assistance Program (SNAP) Participation and Health Care Expenditures Among Low-Income Adults.
JAMA Intern Med. 2017 Nov 1;177(11):1642-1649. doi: 10.1001/jamainternmed.2017.4841.
8
Out-of-Pocket Spending and Premium Contributions After Implementation of the Affordable Care Act.
JAMA Intern Med. 2018 Mar 1;178(3):347-355. doi: 10.1001/jamainternmed.2017.8060.
9
Comparison of the Financial Burden of Survivors of Head and Neck Cancer With Other Cancer Survivors.
JAMA Otolaryngol Head Neck Surg. 2019 Mar 1;145(3):239-249. doi: 10.1001/jamaoto.2018.3982.

引用本文的文献

1
Annual medical expenditure associated with short sleep in China: estimates from a nationally representative sample.
SSM Popul Health. 2025 Apr 29;30:101808. doi: 10.1016/j.ssmph.2025.101808. eCollection 2025 Jun.

本文引用的文献

1
Financial Toxicity Among Patients With Breast Cancer Worldwide: A Systematic Review and Meta-analysis.
JAMA Netw Open. 2023 Feb 1;6(2):e2255388. doi: 10.1001/jamanetworkopen.2022.55388.
2
Racial and Ethnic Disparities in Cancer Care During the COVID-19 Pandemic.
JAMA Netw Open. 2022 Jul 1;5(7):e2222009. doi: 10.1001/jamanetworkopen.2022.22009.
3
AACR Cancer Disparities Progress Report 2022.
Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1249-1250. doi: 10.1158/1055-9965.EPI-22-0542.
6
50 years of the "war on cancer": lessons for public health and geroscience.
Geroscience. 2021 Jun;43(3):1229-1235. doi: 10.1007/s11357-021-00366-6. Epub 2021 Apr 15.
7
Assessment of Racial Disparities in Primary Care Physician Specialty Referrals.
JAMA Netw Open. 2021 Jan 4;4(1):e2029238. doi: 10.1001/jamanetworkopen.2020.29238.
8
Association Between Clinical Value and Financial Cost of Cancer Treatments: A Cross-Sectional Analysis.
J Natl Compr Canc Netw. 2020 Oct 1;18(10):1349-1353. doi: 10.6004/jnccn.2020.7574. Print 2020 Oct.
9
Health Care Expenditure Burden of Cancer Care in the United States.
Inquiry. 2019 Jan-Dec;56:46958019880696. doi: 10.1177/0046958019880696.
10
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection.
Forum Health Econ Policy. 2016 Jun 1;19(1):141-156. doi: 10.1515/fhep-2015-0028.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验